Experimental elimination of tumor necrosis factor in low-dose endotoxin models has variable effects on survival
- PMID: 1855980
- PMCID: PMC258063
- DOI: 10.1128/iai.59.8.2609-2614.1991
Experimental elimination of tumor necrosis factor in low-dose endotoxin models has variable effects on survival
Abstract
Tumor necrosis factor alpha (TNF) is thought to play a major role in the pathogenesis of septic shock. Anti-TNF antibody was preadministered in low-dose endotoxin lethality models in which BALB/c mice were challenged with small amounts of lipopolysaccharide following their sensitization with either carrageenan (CAR) or D-galactosamine (D-GalN). Although the antibody virtually eliminated circulating TNF in both the CAR and the D-GalN models, only the D-GalN model mice were afforded survival, adding to a growing body of evidence that substances other than TNF play a key role in endotoxin-induced lethality. Further examination of sera from these mice showed a much greater elevation of interleukin-6 levels in the CAR-sensitized group than in the D-GalN-sensitized group.
Similar articles
-
Altered expression of constitutive type and inducible type heat shock proteins in response of D-galactosamine-sensitized mice to lipopolysaccharide as an experimental endotoxic shock model.FEMS Immunol Med Microbiol. 1998 May;21(1):37-45. doi: 10.1111/j.1574-695X.1998.tb01147.x. FEMS Immunol Med Microbiol. 1998. PMID: 9657319
-
Increment of plasma soluble CD14 level in carrageenan-primed endotoxin shock model mice.Biol Pharm Bull. 2006 May;29(5):1015-21. doi: 10.1248/bpb.29.1015. Biol Pharm Bull. 2006. PMID: 16651737
-
Ornithine and histidine decarboxylase activities in mice sensitized to endotoxin, interleukin-1 or tumour necrosis factor by D-galactosamine.Br J Pharmacol. 1992 Nov;107(3):888-94. doi: 10.1111/j.1476-5381.1992.tb14542.x. Br J Pharmacol. 1992. PMID: 1472981 Free PMC article.
-
D-galactosamine lethality model: scope and limitations.J Endotoxin Res. 2004;10(3):147-62. doi: 10.1179/096805104225004879. J Endotoxin Res. 2004. PMID: 15198850 Review.
-
Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.Prog Clin Biol Res. 1991;367:141-59. Prog Clin Biol Res. 1991. PMID: 1924424 Review.
Cited by
-
Acute lethal toxicity following passive immunization for treatment of murine cryptococcosis.Infect Immun. 1997 May;65(5):1800-7. doi: 10.1128/iai.65.5.1800-1807.1997. Infect Immun. 1997. PMID: 9125564 Free PMC article.
-
Inhibition of tumor necrosis factor-alpha action within the CNS markedly reduces the plasma adrenocorticotropin response to peripheral local inflammation in rats.J Neurosci. 1997 May 1;17(9):3262-73. doi: 10.1523/JNEUROSCI.17-09-03262.1997. J Neurosci. 1997. PMID: 9096159 Free PMC article.
-
Escherichia coli Braun Lipoprotein (BLP) exhibits endotoxemia - like pathology in Swiss albino mice.Sci Rep. 2016 Oct 4;6:34666. doi: 10.1038/srep34666. Sci Rep. 2016. PMID: 27698491 Free PMC article.
-
Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice.Infect Immun. 1997 Jan;65(1):257-60. doi: 10.1128/iai.65.1.257-260.1997. Infect Immun. 1997. PMID: 8975920 Free PMC article.
-
Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice.Infect Immun. 1995 Apr;63(4):1158-64. doi: 10.1128/iai.63.4.1158-1164.1995. Infect Immun. 1995. PMID: 7890366 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources